Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04578444
Status:
AVAILABLE
Last Update Posted:
2024-04-23
First Post:
2020-09-30
Brief Title:
An Expanded Access Treatment Protocol of Zanidatamab ZW25 in Patients With HER2-Positive Advanced Biliary Tract Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2020-09-30
First Submit QC Date:
September 30 2020
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL